Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial.
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Introduction: The development of resistance by bacterial species is a compelling issue to reconsider indications and administration of antibiotic treatment. Adequate indications and duration of therapy are particularly important for the use of highly potent substances in the intensive care setting. Until recently, no laboratory marker has been available to differentiate bacterial infection from viral or non-infectious inflammatory reaction; however, over the past years, procalcitonin (PCT) is the first among a large array of inflammatory variables that offers this possibility. The present study aimed to investigate the clinical usefulness of PCT for guiding antibiotic therapy in surgical intensive care patients. Methods: All patients requiring antibiotic therapy based on confirmed or highly suspected bacterial infections and at least two concomitant systemic inflammatory response syndrome criteria were eligible. Patients were randomly assigned to either a PCT-guided (study group) or a standard (control group) antibiotic regimen. Antibiotic therapy in the PCT-guided group was discontinued, if clinical signs and symptoms of infection improved and PCT decreased to <1 ng/ml or the PCT value was >1 ng/ml, but had dropped to 25 to 35% of the initial value over three days. In the control group antibiotic treatment was applied as standard regimen over eight days. Results: A total of 110 surgical intensive care patients receiving antibiotic therapy after confirmed or high-grade suspected infections were enrolled in this study. In 57 patients antibiotic therapy was guided by daily PCT and clinical assessment and adjusted accordingly. The control group comprised 53 patients with a standardized duration of antibiotic therapy over eight days. Demographic and clinical data were comparable in both groups. However, in the PCT group the duration of antibiotic therapy was significantly shorter than compared to controls (5.9 +/- 1.7 versus 7.9 +/- 0.5 days, P < 0.001) without negative effects on clinical outcome. Conclusions: Monitoring of PCT is a helpful tool for guiding antibiotic treatment in surgical intensive care patients. This may contribute to an optimized antibiotic regimen with beneficial effects on microbial resistance and costs in intensive care medicine. Annotation: Results were previously published in German in Anaesthesist 2008; 57: 571–577 (PMID: 18463831). Trial registration: ISRCTN10288268
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,796
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 1×
“In addition, Sequential Organ Failure Assessment (SOFA) scores were calculated daily [16] to stratify and monitor disease severity.”
MethodKumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 3×
“Accordingly, Kumar and colleagues [1] could show that the hospital mortality rate for patients with septic shock increased by about 7% per hour within the first six hours of delayed antibiotic administration.”
BackgroundChastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032 · cited 3×
“Singh and colleagues [12] investigated intensive care patients with pneumonia and found that discontinuing antibiotic treatment after three days in the absence of a suspected infection did not worsen outcome.”
BackgroundIregui, M., Ward, S., Sherman, G., Fraser, V. J., & Kollef, M. H. (2002) · Chest · doi:10.1378/chest.122.1.262 · Cited by 956 · cited 1×
“A study from the USA was able to demonstrate that patients with ventilator-associated pneumonia who received antibiotic therapy only 24 hours after established diagnosis, exhibited a seven times higher mortality rate compared with patients started on adequate therapy earlier [21].”
ResultHARBARTH, S., HOLECKOVA, K., FROIDEVAUX, C., PITTET, D., RICOU, B., GRAU, G. E., VADAS, L., PUGIN, J., & the Geneva Sepsis Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2009052 · Cited by 898
Cited by
Items 201–300 of 311
Serum Procalcitonin Assay for Investigations and Clinical Management of Neonatal Sepsis: A Review
Mele, H. U., Babayo, A., Yahaya, F., & Abdullahi, I. N. (2015) · Journal of Pediatric Infectious Diseases · doi:10.1055/s-0035-1554969 · Cited by 11
[Procalcitonin as a marker of intra-abdominal infection].
Domínguez‐Comesaña, E., & Ballinas-Miranda, J. (2014) · PubMed · Cited by 14
The role of immune and metabolic biomarkers for improved management of sepsis patients
Schüetz, P., & Müeller, B. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.932250 · Cited by 9
Biomarkers to Optimize Antibiotic Therapy for Pneumonia Due To Multidrug-Resistant Pathogens
Luyt, C. E., Combes, A., Trouillet, J., & Chastre, J. E. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.05.004 · Cited by 9
Wang, X. J., & Chan, A. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0578-5 · Cited by 10
Chen, G., Sha, Y., Wang, K., Tang, R., Zhai, Z., Wang, Z., & Chen, Y. (2025) · Cureus · doi:10.7759/cureus.78492 · Cited by 11
“Regular assessment of clinical response should include daily evaluation of inflammatory markers, with procalcitonin-guided therapy resulting in a 25%-35% reduction in antibiotic duration without compromising outcomes [67].”
Labro, G., Aptel, F., Puyraveau, M., Paillot, J., Pili‐Floury, S., Merdji, H., Helms, J., Piton, G., Ecarnot, F., Kuteifan, K., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00931-4 · Cited by 9
Bédos, J., Allaouchiche, B., Armand-Lefèvre, L., Baldési, O., Bouadma, L., Decré, D., Figueiredo, S., Gauzit, R., Guery, B. P., Joram, N., et al. (2014) · Réanimation · doi:10.1007/s13546-014-0916-7 · Cited by 11
The value of serum procalcitonin in the anti-infection therapy of acute stroke patients
Wang, H., Li, Y.-L., Li, X., & Wang, Z. (2021) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.37.4.3932 · Cited by 8
Gavazzi, G., Meyrignac, L., Zerhouni, N., Bioteau, C., Lopez, C., François, P., & Drevet, S. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2022.115887 · Cited by 7
August, B., Kale-Pradhan, P. B., Giuliano, C. A., & Johnson, L. B. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2834 · Cited by 9
Strategies of empiric antibiotic therapy in severe sepsis.
Duszyńska, W. (2012) · PubMed · Cited by 7
Surat, G., Meyer-Sautter, P., Rüsch, J., Braun-Feldweg, J., Germer, C., & Lock, J. F. (2022) · Antibiotics · doi:10.3390/antibiotics11010120 · Cited by 13
“Data on the prescribing behavior in cIAIs directed by named markers remain sparse and yet the results, so far, attest PCT a useful tool for both the diagnosis of bacterial infections and discontinuation of antibiotics; yet, it must be stressed that biomarkers should not be read outside the clinical setting [35,37,38].”
MethodUlrich, R. J., McClung, D. M., Wang, B. R., Winters, S. A., Flanders, S. A., & Rao, K. K. (2019) · Infectious Diseases Research and Treatment · doi:10.1177/1178633719852626 · Cited by 9
Infection Management in Patients with Sepsis and Septic Shock in Resource-Limited Settings
Thwaites, L., Lundeg, G., Dondorp, A. M., Adhikari, N. K. J., Nakibuuka, J., Jawa, R. S., Mer, M., Murthy, S., Schultz, M. J., Thien, B. N., et al. (2019) · Springer eBooks · doi:10.1007/978-3-030-03143-5_8 · Cited by 12
Procalcitonin-Guided Antibiotic Therapy Duration in Critically Ill Adults
Walker, C. (2015) · AACN Advanced Critical Care · doi:10.1097/nci.0000000000000079 · Cited by 7
Levine, A. R., Riggott, R., Vulaj, K., Falcetti, T. R., Ali, S. S., & Singh, G. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028017753411 · Cited by 7
“The benefits of using PCT to guide antibiotic therapy in patients with LRTIs and sepsis have been well described in the literature.(8-19) A recent Cochrane systematic review, which included 26 randomized controlled trials among adult patients with acute respiratory tract infections, demonstrated that PCT-directed ther…”
MethodAbdehagh, M., Azimirad, M., Houri, H., Nadalian, B., Azimirad, F., Olfatifar, M., Shoeibi, O. K. N., Yadegar, A., Shahrokh, S., Roshan, M. M., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06804-2 · Cited by 6
“Several studies have previously proposed that serum procalcitonin could be a useful biomarker for early diagnosis of sepsis [33], respiratory infections [34], postoperative infections [35], ventilator-associated pneumonia [36], and severe CDI [32].”
BackgroundSaura, O., & Luyt, C. E. (2023) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2023.2251394 · Cited by 6
Procalcitonin for Antibiotic Treatment in Intensive Care Unit Patients
Layios, N., & Lambermont, B. C. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0360-2 · Cited by 6
Duración del tratamiento antibiótico en la infección intraabdominal
Maseda, E., & Gilsanz, F. (2010) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(10)70030-6 · Cited by 6
Current Diagnosis and Treatment Approach to Sepsis
Akın, A. K., Alp, E., Altındiş, M., Azak, E., Batırel, A. A., Çağ, Y., Durmuş, G., Kurt, E. K., Sağıroğlu, P. Ç., Türe, Z., et al. (2018) · Mediterranean Journal of Infection Microbes and Antimicrobials · doi:10.4274/mjima.2018.17 · Cited by 7
“There is evidence that using PCT monitoring to inform the discontinuation of antibiotic therapy for sepsis may prevent unnecessary prolonged antibiotic use, which may reduce bacterial resistance development as well as medical costs [96,97] .”
Cost-effectiveness of procalcitonin-guided antibiotic duration for hospitalized patients with sepsis
Stevenson, M., Forsyth, J. E., Hossain, A., Lall, R., Dark, P. M., collaborators, A.-S., Carlson, G., Naisbitt, M. J., Kay, D., Barber, S., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05732-w · Cited by 10
Use of biomarkers in the prediction of culture-proven infection in the surgical intensive care unit
Ghabra, H., White, W. A., Townsend, M. C., Boysen, P. G., & Nossaman, B. D. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.10.023 · Cited by 5
Mak, W. Y., He, Q., Yang, W., Xu, N., Zheng, A., Chen, M., Lin, J., Shi, Y., Xiang, X., & Zhu, X. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115447 · Cited by 5
Ingram, N. (2013) · Journal of the Intensive Care Society · doi:10.1177/175114371301400310 · Cited by 5
Personalized treatment of severe pneumonia in cancer patients
Rabello, L. S., Lisboa, T. C., Soares, M., & Salluh, J. I. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1085304 · Cited by 5
Advances in Intra-abdominal Sepsis: What Is New?
Dietch, Z. C., Shah, P. M., & Sawyer, R. G. (2015) · Current Infectious Disease Reports · doi:10.1007/s11908-015-0497-2 · Cited by 6
(SRLF), S. D. R. D. L. F., (Sfar), S. F. D.-R., & Bretonnière, C. (2015) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2015.06.001 · Cited by 5
Willmon, J., Subedi, B., Girgis, R., & Noe, M. M. (2020) · Hospital Pharmacy · doi:10.1177/0018578720925385 · Cited by 7
Host biomarkers for early diagnosis of infectious diseases: A comprehensive review
Chakraborty, A., & Monica, S. (2019) · International Journal of Clinical Microbiology and Biochemical Technology · doi:10.29328/journal.ijcmbt.1001005 · Cited by 4
“Published: June 05, 2019 003 For upper and lower respiratory tract infection in ICU patients with sepsis and post-operative infections, many studies have shown the effectiveness of using PCT algorithms to guide antibiotic choices [23,24].”
Sepsis Management in Resource-Limited Settings
Arslantaş, M. K., & Özdemir, H. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004536 · Cited by 4
The Use of Biomarkers to Track and Treat Critical Illness
Goggs, R. A. N. (2025) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2025.01.010 · Cited by 3
Procalcitonin: Is This the Promised Biomarker for Critically Ill Patients?
Lacroix, J., & Fontela, P. S. (2016) · Journal of Pediatric Intensive Care · doi:10.1055/s-0036-1583279 · Cited by 6
Procalcitonin elevation induced by sympathomimetic drug overdose
Kodama, S., Kashiura, M., & Moriya, T. (2021) · Acute Medicine & Surgery · doi:10.1002/ams2.687 · Cited by 3
Orhan, S., GÜLSOY, K. Y., Yaylagül, E. Ö., Koca, H. B., Yavuz, L., & Ülger, C. (2022) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.21110 · Cited by 3
Palacios, P. V., & Gutiérrez, V. F. I. (2019) · Medicina Crítica · doi:10.35366/87294 · Cited by 3
The Case of Procalcitonin for Lower Respiratory Tract Infections
Stolz, D., & Karakioulaki, M. (2019) · Barcelona Respiratory Network · doi:10.23866/brnrev:2019-0017 · Cited by 4
Procalcitonin in the management of lower respiratory tract infection and sepsis
Elshaboury, R. H., Metlay, J. P., Broyles, M., Rhee, C., Giamarellos‐Bourboulis, E. J., & Mansour, M. K. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf298 · Cited by 3
Kim, M., Seo, M. J., Park, J. E., Choi, M., Chang, H., Heo, S., Maeng, S. J., Lee, G. S., Hwang, S. Y., Ahn, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-48275-y · Cited by 2
“Its levels may be elevated in several noninfectious conditions and assay-related interferences, which restricts its standalone reliability 26–28 .”
Todi, S. K. (2010) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.63027 · Cited by 2
“Two trials addressed this issue last year.[1]”
Procalcitonin as a Diagnostic, Therapeutic, and Prognostic Tool: a Critical Review
de Carvalho, F. R. T., Filho, R. R., Bulgarelli, L., Neto, A. S., & Deliberato, R. O. (2019) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-019-0178-z · Cited by 2
Puspitasari, A. C., & Mawari, A. (2020) · Folia Medica Indonesiana · doi:10.20473/fmi.v56i2.21236 · Cited by 2
Calderón, J. L. M., Guadaño, F. B., Pérez, J. V., & González, R. J. (2015) · Revista del Laboratorio Clínico · doi:10.1016/j.labcli.2014.11.001 · Cited by 2
Dräger, S., Ewoldt, T. M. J., Abdulla, A., Rietdijk, W. J. R., Verkaik, N. J., Ramakers, C. R. B., de Jong, E., Osthoff, M. F., Koch, B. C. P., & Endeman, H. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020270 · Cited by 4
“Although the use of PCT to guide initiation of antibiotic treatment is still debated [28], and its use in guiding the moment to stop antibiotic treatment is more accepted [15,34], PCT values 0.5 ng/mL may be associated with a lower probability of bacterial infection in sepsis patients [28].”
MethodInfluentialMathew, P., Vargese, S. S., Mathew, L. M., David, A., Saji, J. A., & Varghese, A. M. (2024) · Perspectives in Clinical Research · doi:10.4103/picr.picr_298_23 · Cited by 3
“Similar findings have been observed by de Jong et al . in 2016, [15] Nobre et al . in 2008 [16] , and by Hochreiter et al . in 2009 [17] in their respective studies.”
Using Procalcitonin in Septic Shock to Guide Antibacterial Therapy
Sullivan, S. M., & Rueden, K. T. V. (2016) · Dimensions of Critical Care Nursing · doi:10.1097/dcc.0000000000000164 · Cited by 5
“5 ng/mL or had greater than 80% drop in peak PCT levels.(8,16,28,35,36) Utilizing an objective biomarker and an established algorithm,”
BackgroundMethodProcalcitonin in patients with influenza A (H1N1) infection and acute respiratory failure
Duarte, P. A. D., Bredt, C. S. D. O., Bredt, G. L., Jorge, A. C., Venazzi, A., Tondo, L. G., de Oliveira, L. S. C., Jorge, M. M., Marchiori, R. C., Giancursi, T. S., et al. (2011) · Einstein (São Paulo) · doi:10.1590/s1679-45082011ao1878 · Cited by 2
Saleh, R., Youssef, A., & Demerdash, H. (2017) · Research and Opinion in Anesthesia and Intensive Care · doi:10.4103/roaic.roaic_3_17 · Cited by 2
Abdominal and other surgical infections
Brannigan, E., Wong, P. F., & Leaper, D. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-4064-1.00039-7 · Cited by 2
Madhura, N. S., Shashikala, N., Shankar, M., Kowsalya, R., & Mythri, K. (2021) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v12i1.30796 · Cited by 2
Silverstein, D. C., & Otto, C. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-50934-3.00123-3 · Cited by 2
Choi, S. W., Kim, H., Kim, K. H., Shin, D. W., Park, J. S., Roh, J. Y., & Park, J. M. (2011) · The Korean Journal of Critical Care Medicine · doi:10.4266/kjccm.2011.26.4.250 · Cited by 2
Adani, S. D., Zulfariansyah, A., & Santoso, P. T. R. (2017) · Althea Medical Journal · doi:10.15850/amj.v4n2.1088 · Cited by 2
Unraveling the Nature of Antibiotics: Is It a Cure or a New Hurdle to the Patient Treatment?
Gude, S. S., Gopal, S. V., Ramesh, H. M., Vuppalapati, S., Peddi, N. C., & Gude, S. S. (2022) · Cureus · doi:10.7759/cureus.23955 · Cited by 4
“The prevalence of multiresistant organisms is higher in individuals receiving long-term antibiotic therapy, and increased fungal infections even in immunocompetent individuals have become a major source of worry [30].”
BackgroundIt Is all About Risk-Adapted Algorithms
Schüetz, P., & Müeller, B. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e318275cdad · Cited by 2
“Still, previous research focusing on the decrease of PCT postsurgery found lower antibiotic exposure (8), highlighting again that not initiation but rather discontinuation should be the target in this population.”
ResultSchüetz, P., & Wahl, P. M. (2017) · CHEST Journal · doi:10.1016/j.chest.2016.07.014 · Cited by 3
Chamberlain, R. S., Shayota, B. J., Nyberg, C., & Sridharan, P. (2014) · Surgical Science · doi:10.4236/ss.2014.58057 · Cited by 1
“[56] [57] demonstrated that patients in the PCT arm required 2 fewer days of antibiotics (p < 0.”
Procalcitonine chez le sujet âgé : état des lieux
Gavazzi, G. (2010) · Antibiotiques · doi:10.1016/j.antib.2010.02.003 · Cited by 2
Interpreting Procalcitonin at the Bedside
Fazakas, J., Trásy, D., & Molnár, Z. (2016) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-319-27349-5_1 · Cited by 2
The Use of Biomarkers to Track and Treat Critical Illness
Goggs, R. A. N. (2023) · Advances in Small Animal Care · doi:10.1016/j.yasa.2023.07.001 · Cited by 1
Biller, K., Faè, P., Germann, R., Walli, A. K., & Fraunberger, P. (2011) · Journal of Laboratory Medicine · doi:10.1515/jlm.2011.058 · Cited by 1
Gestion de la durée de l’antibiothérapie selon les résultats des biomarqueurs
Quenot, J., Large, A., Dargent, A., Andreu, P., Bruyère, R., Barbar, S. D., & Charles, P. (2016) · Réanimation · doi:10.1007/s13546-016-1180-9 · Cited by 1
How reliable is procalcitonin as an inflammatory marker?1)
Biller, K., Faè, P., Germann, R., Walli, A. K., & Fraunberger, P. (2012) · Journal of Laboratory Medicine · doi:10.1515/jlm.2011.058et · Cited by 1
Das akute Abdomen auf der Intensivstation
Fischer, L., Apitz, M., Billeter, A. T., Hofer, S., & Müller-Stich, B. P. (2017) · Allgemein- und Viszeralchirurgie up2date · doi:10.1055/s-0043-104953 · Cited by 1
“Allgemein- und Viszeralchirurgie up2date 2017; 1 [26] Hochreiter M, Köhler T, Schweiger A et al.”
BackgroundStellenwert des Procalcitonins als Sepsismarker
Kleinbrahm, K., Wappler, F., & Sakka, S. G. (2019) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-0569-7132 · Cited by 1
“Diese Ergebnisse konnten bei operativen Intensivpatienten bestätigt werden [33,34].”
BackgroundGower, S. T. (2012) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
Procalcitonin - potential, limitations and availability
Rimac, V. (2015) · Signa Vitae · doi:10.22514/sv101.062015.26 · Cited by 1
Órgano especificidad de los biomarcadores de sepsis
Ledesma, C. A. (2021) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/46428 · Cited by 2
Layios, N., & Damas, P. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827c04b6 · Cited by 1
Hashemian, S. M. R., & Amir, S. (2012) · InTech eBooks · doi:10.5772/26549
DeLaMater, R. (2012) · SOPHIA (St. Catherine University)
Kahn, R. E. (2009) · Critical Care · doi:10.1186/cc7958
“Irrespective of the study arm and at any time point, the physician in charge had the option to proceed with or to adjust the antibiotic treatment, if there were clinical reasons to do so [1].”
BackgroundResultInfluentialEvaluation of procalcitonin at James Paget Intensive Care Unit
Brodbeck, A., Elumogo, N., & Rajendran, G. (2010) · Critical Care · doi:10.1186/cc8274
Luyt, C., Combes, A., Trouillet, J., Nieszkowska, A., & Chastre, J. E. (2009) · Réanimation · doi:10.1016/j.reaurg.2009.11.009
Uusitalo‐Seppälä, R. (2014) · UTUPub (University of Turku)
Barger, G. (2013) · Research Exchange (Washington State University)
La procalcitonina in Terapia Intensiva: un grande futuro alle spalle?
Dorizzi, R. M., & Sette, P. (2016) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.1007/s13631-016-0112-z
Judicious use of antimicrobial agents in a field of emergency and critical care
Sasaki, J. (2010) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.3893/jjaam.21.871
Shah, S., & Wheeler, D. S. (2013) · Critical Care Medicine · doi:10.1097/01.ccm.0000440035.29313.65
“In critically ill adults, this strategy also demonstrates a 2-4 day reduction in antibiotic prescription in patients with suspected infection without any increase in adverse outcomes [38-43].”
BackgroundTran, L., Ferland, C., & Ang, A. (2016) · Pharmactuel
Usage de la procalcitonine pour guider l’utilisation des antibiotiques en cas de sepsis
Tran, L., Ferland, C., & Ang, A. (2016) · Pharmactuel · Cited by 1
Early procalcitonin kinetics and adequate empiric antibiotic therapy in critically ill
Trásy, D. (2017) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.3892
THE DIAGNOSTIC VALUE OF PROCALCITONIN FOR EARLY DETECTION OF UROSEPSIS
Nasution, M. A. S., Hardjowijoto, S., Soebadi, D. M., Aryati, A., & Pujiraharjo, W. J. (2012) · Indonesian Journal of Urology · doi:10.32421/juri.v19i1.53
Bradley, J. S., Cannavino, C. R., Franzon, D. E., & Duthie, S. E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-07307-3.10094-1 · Cited by 2
Kortgen, A., & Bauer, M. W. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch61
Approach to the Elderly Patient with Delirium: Nursing Perspective
Küçükgüçlü, Ö. (2017) · Springer eBooks · doi:10.1007/978-3-319-65239-9_9
Zhu, Y., Shen, X., Wen, Y., Zhen, W. A. N. G., Zhaobo, W. A. N. G., Xin, D. O. N. G., Li, J., Han, Q., Zhao, J., & Liu, L. (2018) · General Internal Medicine and Clinical Innovations · doi:10.15761/gimci.1000151
Infectious Complications: Understanding Appropriate Antibiotic Choice and Utilization
Sartelli, M. (2019) · Hot topics in acute care surgery and trauma · doi:10.1007/978-3-030-11830-3_14
Collaborating with the Microbiology Laboratory
Forrest, G. N., & Kirsch, D. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316694411.010
Marik, P. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5923-2_12
Review: Advances in the Detection of PCT Infection after Urology Surgery
周, 强. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.1111724
Good clinical practice and scientific research in the EU - Rome, 2-4 November 2011
Editors, T. M. A. F. C. D. (2012) · Emergency Care Journal · doi:10.4081/ecj.2012.1.15
Mohammed, Y. Z., Al-Hameid, S. A., & El-Naggar, A. (2023) · International Journal of Medical Arts · doi:10.21608/ijma.2023.236754.1814
Das aktute Abdomen auf der Intensivstation
Fischer, L., Iber, T., Billeter, A. T., Hofer, S., Müller-Stich, B. P., Kolb, G., & Apitz, M. (2024) · Allgemein- und Viszeralchirurgie up2date · doi:10.1055/a-2367-3718
Das aktute Abdomen auf der Intensivstation
Fischer, L., Iber, T., Billeter, A. T., Hofer, S., Müller-Stich, B. P., Kolb, G., & Apitz, M. (2024) · Intensivmedizin up2date · doi:10.1055/a-2435-1940
KHẢO SÁT NỒNG ĐỘ PROCALCITONIN Ở NGƯỜI BỆNH SAU PHẪU THUẬT TIM
An, D. B., Thảo, N. T. T., & Phước, N. T. H. (2025) · Tạp chí Sức khỏe và Lão hóa · doi:10.63947/bvtn.v1i3.8
Procalcitonin and Antibiotic Exposure in the ICU: The PRORATA Trial
Chacko, J., Chalfin, D. B., Seppelt, I., Pawar, S., & Brar, G. (2025) · Springer eBooks · doi:10.1007/978-981-95-0673-6_49
Péju, E., Dargent, A., Roudaut, J.-B., Prin, S., Andreu, P., Large, A., Quenot, J., & Charles, P. (2025) · Antibiotics · doi:10.3390/antibiotics14101012
“Other well-conducted studies were performed so far, with different algorithms (e.g., different PCT thresholds or decreasing rate) [9,13,17,18].”
Place des biomarqueurs pour le diagnostic et le suivi des infections en réanimation
Daubin, C., Seguin, A., & Valette, X. (2013) · Références en réanimation · doi:10.1007/978-2-8178-0389-0_9
Metadata
- Authors
- Hochreiter, M., Köhler, T., Schweiger, A. M., Keck, F. S., Bein, B., von Spiegel, T., & Schroeder, S.
- Affiliations
- Westküstenkliniken Brunsbüttel und Heide gGmbH (DE)
- University Hospital Schleswig-Holstein (DE)
- Venue
- Critical Care
- Published
- 2009-06-03
- Volume
- 13
- Issue
- 3
- Pages
- R83-R83
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2717450
- OpenAlex
- W2109928541
- Semantic Scholar
- 269d1d25f4ebc2ac9fd79ee6e50e38b8ebd7138d
- Cited by
- 315
- References
- 29
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 10 · 2023: 13 · 2022: 10 · 2021: 22 · 2020: 9 · 2019: 16 · 2018: 21 · 2017: 32 · 2016: 18 · 2015: 23 · 2014: 18 · 2013: 28 · 2012: 32
- FWCI
- 17.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- procalcitonin, antibiotic duration, antibiotic stewardship, surgical intensive care patients, bacterial infection, systemic inflammatory response syndrome, antibiotic de-escalation, antimicrobial resistance, inflammatory markers
- MeSH terms
- Aged, Anti-Bacterial Agents, Calcitonin, Diagnosis, Differential, Female, Humans, Male, Postoperative Complications, Prospective Studies, Protein Precursors, Biomarkers, Calcitonin Gene-Related Peptide, Drug Monitoring, Systemic Inflammatory Response Syndrome, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.